Immunologic mapping of glycomes: implications for cancer diagnosis and therapy

  • Zhou D
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Cancer associated glycoconjugates are important biomarkers, as exemplified by globo-H, CA125, CA15.3 and CA27.29. However, the exact chemical structures of many such biomarkers remain unknown because of technological limitations. In this article, we propose the "immunologic mapping" of cancer glycomes based on specific immune recognition of glycan structures, which can be hypothesized theoretically, produced chemically, and examined biologically by immuno-assays. Immunologic mapping of glycans not only provides a unique perspective on cancer glycomes, but also may lead to the invention of powerful reagents for diagnosis and therapy.

Cite

CITATION STYLE

APA

Zhou, D. (2011). Immunologic mapping of glycomes: implications for cancer diagnosis and therapy. Frontiers in Bioscience, S3(1), 1520. https://doi.org/10.2741/242

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free